跳至主要内容
临床试验/NCT02004015
NCT02004015终止4 期

Effect of an Induction Dose of Non Depolarizing Neuro Muscular Blocking Agents (NMBA) on Ultrasound Bowel Peristalsis.

Fondation Ophtalmologique Adolphe de Rothschild1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2013年11月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
终止
入组人数
50
试验地点
1
主要终点
Proportion of patients with a score of motion = 0

研究概览

简要总结

Phase III prospective randomised study : curare vs placebo, comparing bowel peristalsis (abdominal echography) in the first minutes of after general anesthesia induction.

Primary End Point: proportion of patients with a score of motion = 0

详细描述

Primary End Point Proportion of patients with a score of motion = 0

Secondary End Point Time at which thumb adductor twitch measurement disappears (3rd consecutive measure with a twitch at 0) Mean minimal twitch measurement for those patients in who twitch measurement does not disappear Concordance study between twitch measurement and bowel peristalsis XML File Identifier: 1vUwHz2uUXeSc7soLu1cQwRAfcM= Page 15/24 ultrasound score.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • elective surgery
  • scheduled oro tracheal intubation

排除标准

  • Counter indication to NMBA:
  • predicted difficult airway
  • surgical counter indication: facial or laryngeal nerve function monitoring
  • allergy to muscle relaxants neuro muscular disease Possible alteration of sensitivity to muscle relaxants due to ongoing medication: ex Valproate or aminoglycoside antibiotics. Predictable alteration of bowel movements or difficult abdominal ultrasound:
  • scheduled abdominal surgery
  • abdominal surgery in last month
  • obesity: body mass index over 30 Full stomach or pregnancy requiring suxamethonium for intubation

研究组 & 干预措施

Atracurium

Experimental

injection of NMBA 0.5 mg/kg milligram(s)/kilogram in Intravenous bolus use

干预措施: injection of NMBA (Drug)

ROCURONIUM

Experimental

injection of NMBA 0.6 mg/kg milligram(s)/kilogram in Intravenous bolus

干预措施: injection of NMBA (Drug)

placebo

Placebo Comparator

injection of placebo Injection in Intravenous bolus use

干预措施: injection of placebo (Drug)

结局指标

主要结局

Proportion of patients with a score of motion = 0

时间窗: 10 minutes after NMBA or placebo injection

Proportion of patients with a score of motion = 0

次要结局

  • Time at which thumb adductor twitch measurement disappears(1 month after injection)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验